Suppr超能文献

“潘奈特·萨尔布教授博士”医院在乳腺癌患者肿瘤生育力方面的经验。

Experience of the "Prof. Dr. Panait Sarbu" Hospital in Oncofertility among Breast Cancer Patients.

作者信息

Iordache Ioana, Odukoya Cristiana, Carp-Veliscu Andreea, Bordea Alina Elena, Bratila Elvira

出版信息

Chirurgia (Bucur). 2021 Mar-Apr;116(2 Suppl):105-109.

Abstract

Oncofertility represents a new field, dedicated to patients at childbearing age who are diagnosed with a neoplasic disease and who want to have a biologic child after they complete the oncological and surgical treatment. Because of new screening and treatment methods, most patients survive the disease, but the main long-term complication remains infertility. Young women with breast cancer are candidates for preserving their fertility mostly because of the risk of chemotherapy-related infertility due to the alkylating agent, causing dose-dependent destruction of oocytes and follicular depletion and thus bringing cortical fibrosis and ovarian blood-vessel damage (1). "Prof. Dr. Panait S #226;rbu" hospital is the first medical facility in Romania which performs oncofertility procedures among breast cancer patients within the program "Newborn Oncofertility". Material and Within the program run by our hospital 21 patients (13 men and 8 women) came for fertility preservation, including 5 patients diagnosed with breast cancer. Our specialists in reproductive medicine performed ovarian stimulation and oocyte pick-up, after which the genetic material was cryopreserved. The procedure could be performed only if the patients were under 35 years old, and provided the case had been previously discussed within the tumor board and the patient had received the oncological agreement. Disscution: There was a slight predominance of breast cancer patients who addressed the clinic with a view for preserving their fertility and those who met the conditions could start the procedure immediately, without any delay when it comes to oncological or surgical treatments. There were no side effects during ovarian stimulation treatment. Oocytes or embryos were cryopreserved using the method of vitrification.

摘要

肿瘤生育学是一个新领域,致力于为育龄期被诊断患有肿瘤疾病且在完成肿瘤及外科治疗后希望生育亲生子女的患者服务。由于新的筛查和治疗方法,大多数患者能够战胜疾病,但主要的长期并发症仍然是不孕不育。患有乳腺癌的年轻女性大多是保留生育能力的候选者,这主要是因为烷化剂导致的化疗相关不孕风险,会造成剂量依赖性的卵母细胞破坏和卵泡耗竭,进而导致皮质纤维化和卵巢血管损伤(1)。“潘奈特·塞尔布教授博士”医院是罗马尼亚第一家在“新生儿肿瘤生育学”项目中为乳腺癌患者实施肿瘤生育程序的医疗机构。材料与方法 在我们医院开展的该项目中,有21名患者(13名男性和8名女性)前来寻求生育力保存,其中包括5名被诊断患有乳腺癌的患者。我们的生殖医学专家进行了卵巢刺激和卵母细胞采集,之后将遗传物质进行了冷冻保存。仅当患者年龄在35岁以下,且该病例此前已在肿瘤委员会进行过讨论且患者已获得肿瘤学方面的同意时,才能进行该程序。讨论:前来诊所希望保留生育能力的乳腺癌患者略占多数,符合条件的患者可以立即开始该程序,在肿瘤学或外科治疗方面不会有任何延误。卵巢刺激治疗期间没有出现副作用。采用玻璃化方法对卵母细胞或胚胎进行了冷冻保存。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验